Onconetix, Inc. Management And Service Fees Rate
Onconetix, Inc. (ONCO) reported Management And Service Fees Rate of 1.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Financial Services › Investment Company › Investment Company, Disclosure Items
us-gaap:ManagementAndServiceFeesRate · last filed 2026-03-13
- Onconetix, Inc. management and service fees rate for fiscal 2025 was 1.00%, a 0.00% change from fiscal 2024.
- Onconetix, Inc. management and service fees rate for fiscal 2024 was 1.00%.
| Period end | Management And Service Fees Rate 6 month | Management And Service Fees Rate 9 month | Management And Service Fees Rate 12 month |
|---|---|---|---|
| 2025-12-31 | 1.00% 10-K · filed 2026-03-13 | ||
| 2024-12-31 | 1.00% 10-K · filed 2025-06-02 | ||
| 2024-09-30 | 1.00% 10-Q · filed 2024-12-10 | ||
| 2024-06-30 | 1.00% 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |